// App-Quantinova.ai

1406 : Are circulating microRNAs (miRNAs) ready for inclusion as biomarkers in breast cancer clinical trials

Researchers

Presenter

  • Edward B. Amankwatia

Principal Investigators

  • Alexandra Bennett

  • David Ou

  • David Jamieson

  • Nicola Cresti

  • Henry Cain

  • Rosie McNeillis

  • Jonathan Womack

  • Sacha Howell

  • Michelle Harvie

  • Felicity May

  • Alastair Greystoke

Medical Centers

  • Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom

  • Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom

  • Department ofAnaeshesia, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom

  • Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • miR-16

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • ISRCTN04156504

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved